methods: search

Internet Marketing Methods To Attract Targeted Website Traffic

Driving targeted traffic to a website is where a lot of people seem to have difficulty. Generating traffic does take daily consistent effort but it is not difficult, you just need to have time, perseverance and patience. Whilst there are several reliable methods this guide looks at 5 free internet marketing methods that you can use to drive traffic to your website.

U.S. patents granted to Virginia Tech for targets and methods to develop new drugs for malaria

Add our medical news to StumbleUpon - U.S. patents granted to Virginia Tech for targets and methods to develop new drugs for malaria Add our medical news to Facebook - U.S. patents granted to Virginia Tech for targets and methods to develop new drugs for malaria

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency...

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics Zamore Patent Covers Methods for Enhancing RNAi Structural Features and Strengthens Intradigm's Competitive Position PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issued patent, which is based on the seminal research of Philip Zamore, Ph.D., the Gretchen Stone Cook Chair of Biomedical Sciences and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of an RNAi agent through certain str

DAIRY COMPOSITION WITH HIGH-POTENCY SWEETENER [European Patents]

PRAKASH, Indra DUBOIS, Grant, E. Title DAIRY COMPOSITION WITH HIGH-POTENCY SWEETENER Abstract The present invention relates generally to dairy compositions comprising non-caloric or low-caloric high-potency sweeteners and methods for making and using them. In particular, the present invention relates to different dairy compositions comprising at least one non-caloric or low-caloric natural and/or synthetic high-potency sweetener, at least one sweet taste improving composition, and a dairy product. The present invention also relates to dairy compositions and methods that can improve the tastes of non-caloric or low-caloric natural and/or synthetic, high-potency sweeteners by imparting a more sugar-like taste or characteristic. In particular, the dairy compositions and methods provide a more sugar-like temporal profile, including sweetness

Modern Methods For Sharing Innovation

The New York Times is running a story about Johnny Chung Lee, a hardware hacker made famous for his projects which modified the Nintendo Wiimote to do things like positional head tracking and multi-touch display control. The article focuses on the suggestion that Lee's use of YouTube to demonstrate his innovations has done a better job of communicating his ideas than more traditional methods could. Quoting: "He might have published a paper that only a few dozen specialists would have read. A talk at a conference would have brought a slightly larger audience. In either case, it would have taken months for his ideas to reach others. Small wonder, then, that he maintains that posting to YouTube has been an essential part of his success as an inventor.

C# Partial Methods

C# 2.0 introduced partial types to allow class definitions to be split between several files. C# 3.0 extends the concept with partial methods, allowing method signatures to be declared but not implemented. This is ideal for use with code generation tools.

C# Extension Methods

Sometimes it is necessary to add functionality to a library for which you do not own the source code and where using inheritance to subclass functionality is not viable. This problem can be overcome with the careful use of C# 3.0 extension methods.

Court rejects business methods patents: Good or bad for tech?

Now that the U.S. Court of Appeals has ruled that abstract processes, or business methods, cannot be patented, it's important to look at how this could affect the tech industry.

Invalidation of Business-Methods Patents Has Broad Implications

If you are one of the recipients of the 1,330 business method patents issued in the U.S. last year, or the thousands more that have been issued rampantly and indiscriminately over the past decade, you are probably out of luck. The U.S. Court of Appeals in Washington, D.C. ruled today that business methods are not patentable unless they meet fairly narrow rules. What this means for Internet companies and patent trolls alike is that many of their existing patents may be invalid — at least until the case is heard by the Supreme Court, assuming it is appealed.

Internet Marketing Firm Is Using New Search Engine Marketing Methods to Increase Visibility and Revenue for Businesses

Internet Marketing Firm Is Using New Search Engine Marketing Methods to Increase Visibility and Revenue for Businesses

Federal Court Limits Patents on Business Methods

Ten years ago, in a case called State Street Bank vs. Signature Financial Group, a federal circuit court found that novel methods for doing business on computers were patentable. That opened the gates to a flood of “business method patentsâ€� of features like Amazon.com’s “1-Clickâ€� checkout and Priceline.com’s “name your own price� tools, which involve less technological ingenuity than ethereal inventiveness and legal muscle.

Federal Circuit Restricts Patent Protection of Business Methods

Drilling into the core of patent eligibility, a federal appeals court on Thursday issued a rare full-court opinion that restricts the patent protection of business methods.

Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods

Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods

Redpoint Bio Corporation Receives Two U.S. Patents Covering Compositions and Methods for Low-Sodium Salt Substitute

a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced the issuance of Patents No. 7,452,563 and 7,455,872, by the U.S. Patent and Trademark Office, covering compositions and methods for its low-sodium salt substitute called Betrasalt(R).

Redpoint Bio Corporation Receives Two U.S. Patents Covering Compositions and Methods for Low-Sodium Salt Substitute

Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced the issuance of Patents No. 7,452,563 and 7,455,872, by the U.S. Patent and Trademark Office, covering compositions and methods for its low-sodium salt substitute called Betrasalt®.

Redpoint Bio Corporation Receives Two U.S. Patents Covering Compositions and Methods for Low-Sodium Salt Substitute

EWING, N.J. - (Business Wire) Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced the issuance of Patents No. 7,452,563 and 7,455,872, by the U.S. Patent and Trademark Office, covering compositions and methods for its low-sodium salt substitute called Betrasalt®.

Blogging Lessons Part 7 - Getting More Traffic to Your Blog

Getting links from other websites is not the only way to attract visitors to visit your blog. This time, we are going to explore alternative methods to attract high quality traffic with both free and paid methods.

EU patent board to decide whether to allow software patents (ars technica)

Although EU patent law expressly excludes patenting software as such, it does allow patents to be granted for computer-implemented inventions. There are, however, many unanswered questions about the distinction between software methods and computer-implemented inventions. In practice, the EPO has historically granted patent applications in some cases for software methods that are viewed as legitimate technical innovations rather than business innovations. The EPO illustrates the difference by saying that a patent on a software method for improving signal strength between mobile phones is likely to be valid, but a patent on Internet auction systems is probably not.

PHARMACEUTICAL COMPOSITION COMPRISING HIGH-POTENCY SWEETENER [European Patents]

PRAKASH, Indra DUBOIS, Grant, E. Title PHARMACEUTICAL COMPOSITION COMPRISING HIGH-POTENCY SWEETENER Abstract The present invention relates generally to pharmaceutical compositions comprising non-caloric or low-caloric high-potency sweeteners and methods for making and using them, in particular, the present invention relates to different pharmaceutical compositions comprising at least one non-caloric or low-caloric natural and/or synthetic high-potency sweetener, at least one sweet taste improving composition, and a pharmaceutically active substance. The present invention also relates to pharmaceutical compositions and methods that can improve the tastes of non-caloric or low-caloric natural and/or synthetic, high- potency sweeteners by imparting a more sugar-like taste or characteristic.

Q&A With Post-Quantum Computing Cryptography Researcher Jintai Ding

Quantum computers may be the perennial “computer of the future,� but if (or when) they do become a reality, their sheer power could threaten the security of our information-technology infrastructure. Online shopping, e-mail, and automatic software updates rely on public-key cryptography methods to ensure those transactions are safe. The two main methods of public-key cryptography are RSA, which is based on an algorithm that relies on the difficulty of factoring large numbers, and elliptic-curve cryptography (ECC), which is based on the mathematical structure of elliptical curves. But a quantum computer could quickly crack either cryptosystem. In October, the University of Cincinnati hosted an international cryptography conference with industry and government experts to address this very problem.

AVI BioPharma strengthens patent position in exon skipping

AVI BioPharma, Inc, a developer of RNA-based drugs, has signed an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD). The patent application, 'Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof' (US Patent publication number US2008/0200409 A1 and foreign counterparts) claims compositions and methods for treating DMD in humans by skipping exons in the dystrophin gene using antisense oligomers. Among the inventors on the licensed patent application is Stephen D Wilton, head of the Molecular Genetic Therapies Group at UWA, a renowned pioneer in the use of exon skipping to treat DMD.

AVI BioPharma Strengthens Patent Position in Exon Skipping

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD). The patent application, "Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof" (U.S. Patent publication number US2008/0200409 A1 and foreign counterparts) claims compositions and methods for treating DMD in humans by skipping exons in the dystrophin gene using antisense oligomers. Among the inventors on the licensed patent application is Stephen D. Wilton, Ph.D., Head of the Molecular Genetic Therapies Group at UWA, a renowned pioneer in the use of exon skipping to treat DMD.

AVI BioPharma Strengthens Patent Position in Exon Skipping

PORTLAND, OR--(MARKET WIRE)--Nov 24, 2008 -- AVI BioPharma, Inc. (NasdaqGM:AVII - News), a developer of RNA-based drugs, today announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD). The patent application, "Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof" (U.S. Patent publication number US2008/0200409 A1 and foreign counterparts) claims compositions and methods for treating DMD in humans by skipping exons in the dystrophin gene using antisense oligomers. Among the inventors on the licensed patent application is Stephen D. Wilton, Ph.D., Head of the Molecular Genetic Therapies Group at UWA, a renowned pioneer in the use of exon skipping to treat DMD.

C++ CLR Compilation

The C++ compiler has the ability to produce both native and managed instructions. The /clr compiler switch is the basic option for turning managed instruction generation on and off, but beginning with Visual C++ 2005, finer grained control over managed instruction generation is possible. Managed code can be written using C++/CLI in a manner that is verifiably type-safe, which means that it can be statically analyzed to ensure that it only accesses the member variables and methods of a type correctly. Without verifiable type safety, pointer arithmetic can be used to access methods and member variables indirectly, potentially bypassing the inbuilt security checks that are present in the .NET runtime. A binary that is verifiably type-safe can be hosted in more environments, like SQL Server and hosted environments, and can be deployed in more

Search took 0.02 seconds.